Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Maureen Okam Achebe, MD, MPH
Healthcare Provider Clinical Director
Non-Malignant Hematology Clinic
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, Massachusetts, United States
Dr. Maureen M. Okam studied medicine at University of Port Harcourt Medical School (1995). Her interests are hematologic disorders, anemia, sickle cell disease and thalassemia, thrombosis and anticoagulant therapy, thrombocytopenia, myelodysplasia and myeloproliferative disorders.
Her current research focuses on the pre-clinical and clinical development of new agents for the treatment of hemoglobinopathies – sickle cell disease and thalassemia. Her on-going clinical evaluation of histone deacetylase inhibitors in the induction of fetal hemoglobin, is funded by the National Institutes of Health through a Harvard Blood Scholars research grant.
Appointments:
Clinical Director, Non-Malignant Hematology Clinic
Assistant Director, Brigham and Women’s Hospital Outpatient Infusion Center
Director, Brigham and Women’s Hospital Sickle Cell Program
Assistant Professor in Medicine, Harvard Medical School
+myBinderRelated Content
-
A Randomized Trial of Yoga for Children Hospitalized With Sickle Cell Vaso-Occlusive CrisisContext: Sickle cell disease (SCD) vaso...
-
Dora Clayton-Jones, RN, PhD, CPNP-PCDr. Dora Clayton-Jones is an Assistant P...
-
Duke University Comprehensive Sickle Cell CenterHematologists at the Duke University Com...
-
Abdullah Kutlar, MDDr. Kutlar has served Augusta University...
-
A Multidisciplinary Approach to Impact Acute Care Utilization in Sickle Cell DiseaseSickle cell disease (SCD), an inherited ...
-
Blood Industry Joins Together During Coronavirus Challengeshttps://www.youtube.com/watch?v=Z3V_DX_A...
-
‘Every Time It’s A Battle’: In Excruciating Pain, Sickle Cell Patients Are Shunted AsideAmy Mason had toughed it out for hours o...
